AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Rakesh Awasthi

Rakesh Awasthi

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4389714
-
person_outline Rakesh Awasthi's MOST POPULAR ARTICLES
1-) Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma New England Journal of Medicine 380 (1), 45-56, 2019
2-) Second-line tisagenlecleucel or standard care in aggressive B-cell lymphoma New England Journal of Medicine 386 (7), 629-639, 2022
3-) Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial Nature medicine 28 (2), 325-332, 2022
4-) Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia Blood, The Journal of the American Society of Hematology 130 (21), 2317-2325, 2017
5-) Clinical pharmacology of tisagenlecleucel in B-cell acute lymphoblastic leukemia Clinical cancer research 24 (24), 6175-6184, 2018